Enhancing guideline-based asthma care processes through a multi-state, multi-center quality improvement program.
Adult
Ambulatory Care
/ methods
Anti-Asthmatic Agents
/ administration & dosage
Asthma
/ diagnosis
Community Health Services
/ organization & administration
Disease Management
Female
Humans
Male
Middle Aged
Practice Guidelines as Topic
Prognosis
Program Evaluation
Quality Improvement
Retrospective Studies
Risk Assessment
Treatment Outcome
United States
Asthma
guideline‐based measures
quality improvement program
quality measures
real‐world analysis
Journal
The Journal of asthma : official journal of the Association for the Care of Asthma
ISSN: 1532-4303
Titre abrégé: J Asthma
Pays: England
ID NLM: 8106454
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
pubmed:
12
4
2018
medline:
6
5
2020
entrez:
12
4
2018
Statut:
ppublish
Résumé
This study investigated the effectiveness of Enhancing Care for Patients with Asthma (ECPA)-a collaborative quality improvement program implemented in 65 community health centers that serve asthma patients in four states-on clinic-based asthma performance measures consistent with national guidelines. This study utilized a pretest-posttest quasi-experimental design. Six clinic-based performance measures of each center were collected from a retrospective chart review at time points: before the ECPA implementation; at the end of the 12-month long ECPA program; and 6 months after program completion. The effectiveness of the ECPA was assessed using generalized linear mixed models with a Poisson distribution and log link by evaluating the change in each measure from baseline to program completion, from baseline to 6-month post-program completion and from program completion to 6-month post-program completion. The ECPA implementation was positively associated with improvement in all measures from baseline to program completion: documentation of asthma severity (rate ratio (RR) 1.314; 95% confidence interval (CI) 1.206, 1.432); Asthma Control Test (RR 3.625; 95% CI 3.185, 4.124); pulmonary function testing (RR 1.771; 95% CI 1.527, 2.054), asthma education (RR 2.246; 95% CI 2.018, 2.501), asthma action plan (RR 2.335; 95% CI 2.070, 2.634) and controller medication (RR 1.961; 95% CI 1.504,2.556). Improvement was sustained for all six measures at the 6-month post-program completion time point. This study demonstrated the favorable effect of the ECPA program on evidence-based asthma quality measures. This program could be considered a model worth replication on a broader scale.
Identifiants
pubmed: 29641271
doi: 10.1080/02770903.2018.1463378
doi:
Substances chimiques
Anti-Asthmatic Agents
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM